Search

Competing Interests: Les auteurs déclarent n’avoir aucun lien d’intérêts.

Competing Interests: Les auteurs déclarent n’avoir aucun lien d’intérêts.

Competing Interests: Les auteurs déclarent n’avoir aucun lien d’intérêts.

Dengue fever: an emerging infectious disease. Dengue fever is caused by an arbovirus of the family Flaviviridae and the genus Flavivirus, of which there are 4 serotypes (DEN-1, DEN-2, DEN-3, DEN-4). It is transmitted by the bite of a diurnal mosquito of the genus Aedes, mainly A. aegypti and A. albopictus. An increasing cause of acute fever in travellers, it threatens to emerge in temperate regions where competent mosquitoes (Aedes) are established. Dengue fever is characterized by its clinical polymorphism ranging from asymptomatic to severe forms, which are rare in travellers. Its definite diagnosis is based on virological tests selected according to the stage of the disease and the kinetics of the virus. Its treatment is only symptomatic. It is a notifiable disease in mainland France and is subject to a plan to combat its spread and to specific surveillance in the overseas departments. Dengue prevention is based on the application of personal anti-vectorial protection measures among travellers, awareness-raising among health professionals and social mobilization to combat larval gites in endemic regions or regions colonized by Aedes. In France, the tetravalent vaccine Dengvaxia, which is licensed in France, is not recommended for people residing in overseas departments and for travelers to endemic areas., Competing Interests: C. Rapp déclare participer ou avoir participé à des interventions ponctuelles pour le laboratoire Alfasigma France.

Competing Interests: Les auteurs déclarent n’avoir aucun lien d’intérêts.

Self and hetero evaluation of cancer treatment side effects. The accurate and continuous assessment of the side effects of cancer treatments is a major factor in the quality of patient care. The combination of self-evaluation by the patient himself and hetero-evaluation by health professionals makes it possible to optimize the follow-up of the patients and to better adapt the therapeutics. The use of connected devices and modern communication tools fits in perfectly with the need for regular monitoring of patients, which also makes the best use of professional resources., Competing Interests: M. Di Palma déclare avoir des liens ponctuels avec Amgen, Novartis, Sandoz, Frenesius, Sanofi, Pfizer etc. -liste non exhaustive-.

Competing Interests: Les auteurs déclarent n’avoir aucun lien d’intérêts.

Ogilvie's syndrome and chronic intestinal pseudo-obstructions are two aspects of non-mechanical obstruction. The syndrome consists of acute colonic obstruction due to multiple causes and is characterized by passive dilatation of the colon without downstream obstacle. Treatment is primarily medical, except in cases with complications such as perforation by symptomatic treatment and, sometimes, by decompression colonoscopy. The most severe complication is perforation of the colon which may require colonic excision. Chronic intestinal pseudo-obstruction is characterized by chronic disorders mostly due to abnormalities of nervous plexuses and smooth muscle of the small and large bowels. It occurs in children and surgical abstention may lead to repeated but unfortunately ineffective operations. The only treatment recognized is digestive tract bypass combined with total parenteral feeding.